Therapeutic Pancreatic Endoscopy

In view of increasingly accurate noninvasive diagnostic imaging modalities for pancreatic diseases, endoscopic retrograde cholangiopancreatography (ERCP) should be mainly restricted to therapeutic indications. Acute pancreatitis is still the most common complication of ERCP. Prevention measures should focus in particular on well-defined risk groups. Temporary pancreatic duct drainage, preferably using small-diameter endoprostheses, can reduce the incidence of post-ERCP pancreatitis in at-risk individuals. By contrast, pharmacological prevention does not appear to be effective. ERCP in conjunction with sphincter of Oddi manometry frequently reveals the diagnosis of undetermined causes of acute recurrent pancreatitis. Endoscopic sphincterotomy (EST) is the treatment of choice in patients with sphincter of Oddi dysfunction or papillary stenosis. For these indications, dual pancreaticobiliary sphincterotomy promises a lower early morbidity and a better long-term outcome than biliary EST alone. In patients with pancreatic divisum, the cannulation rate of the dorsal duct can be improved by methylene blue staining and/or stimulation of the pancreatic secretion. Papillotomy of the minor papilla with short-term stenting appears to be an effective and safe approach for associated acute recurrent pancreatitis. Large-scale trials indicate that the majority of symptomatic patients with chronic pancreatitis can be well managed in the long term by endoscopic interventions. There is still a lack of prospective randomized controlled trials on endotherapy for chronic pancreatitis; however, they are also lacking for the surgical approach. Endoscopic and/or endosonographically guided drainage has become the treatment of choice for the majority of symptomatic pancreatic pseudocysts. Transmural debridement of pancreatic abscesses and infected necroses is still investigational, but appears to offer a minimally invasive alternative to surgery in selected cases. Pancreatic endotherapy is technically demanding and potentially hazardous; these interventions should be restricted to high-volume centers with options for an interdisciplinary team approach. Methods that have not yet been established should be evaluated in carefully designed prospective trials.

References

• 1 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434
• 2 Akashi R, Kiyozumi T, Tanaka T. et al . Mechanism of pancreatitis caused by ERCP.  Gastrointest Endosc. 2002;  55 50-54
• 3 Andriulli A, Clemente R, Solmi L. et al . Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.  Gastrointest Endosc. 2002;  56 488-495
• 4 Andriulli A, Caruso N, Quitadamo M. et al . Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.  J Pancreas. 2003;  4 41-48
• 5 Manolakopoulos S, Avgerinos A, Vlachogiannakos J. et al . Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.  Gastrointest Endosc. 2002;  55 470-475
• 6 Sherman S, Blaut U, Watkins J L. Does prophylactic administration of corticoid reduce the risk and severity of post-ERCP pancreatitis? A randomized, prospective, multicenter study.  Gastrointest Endosc. 2003;  58 23-29
• 7 Moretó M, Zaballa M, Casado I. et al . Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial.  Gastrointest Endosc. 2003;  57 1-7
• 8 Kaffes A, Alrubaie A, Ding N. et al . A prospective, randomized, double-blind, placebo-controlled trial of transdermal glyceryl trinitrate in technical success of ERCP and prevention of post-ERCP pancreatitis: preliminary results [abstract].  Gastrointest Endosc. 2003;  57 AB 191
• 9 Fazel A, Quadri A, Catalano M F. et al . Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
• 10 Singh P, Sivak M V, Agarwal D. et al . Prophylactic pancreatic stenting for prevention of post-ERCP acute pancreatitis: a meta-analysis of controlled trials [abstract].  Gastrointest Endosc. 2003;  57 AB 89
• 11 Rashdan A, Fogel E L, McHenry L. et al . Pancreatic ductal changes following small-diameter, long-length, unflanged pancreatic duct stent placement [abstract].  Gastrointest Endosc. 2003;  57 AB 213
• 12 Raju G S, Gomez G, Xiao S Y. Short-term pancreatic stenting leads to a rapid onset of inflammation, fibrosis, and acinar loss [abstract].  Gastrointest Endosc. 2003;  57 AB 88
• 13 Abe R, Shimosegawa T. Development of a bent-type tube stent for simultaneous drainage of bile and pancreatic juice.  J Hepatobiliary Pancreat Surg. 2002;  9 600-602
• 14 Tarnasky P R. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications.  J Pancreas. 2003;  4 58-67
• 15 Kaw M, Brodmerkel G J. ERCP biliary crystal analysis, and sphincter of Oddi manometry in idiopathic pancreatitis.  Gastrointest Endosc. 2002;  55 157-162
• 16 Coyle W J, Pineau B C, Tarnasky P R. et al . Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound.  Endoscopy. 2002;  34 617-623
• 17 Park S, Watkins J L, Fogel E L. et al . Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.  Gastrointest Endosc. 2003;  57 483-491
• 18 Fogel E L, Eversman D, Jamidar P. et al . Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.  Endoscopy. 2002;  34 280-285
• 19 Choudari C P, Nickl N J, Fogel E L. et al . Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy.  Gastrointest Endosc. 2002;  56 66-71
• 20 Devereaux B M, Lehman G A, Fein S. et al . Facilitation of pancreatic duct cannulation using a new synthetic porcine secretin.  Am J Gastroenterol. 2002;  97 2279-2281
• 21 Park S, de Bellis M, McHenry L. et al . Use of methylene blue to identify the minor papilla or its orifice in patients with pancreas divisum.  Gastrointest Endosc. 2003;  57 358-363
• 22 Heyries L, Barthet M, Delvasto C. et al . Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis.  Gastrointest Endosc. 2002;  55 376-381
• 23 Gabbrielli A, Mutignani M, Pandolfi M. et al . Endotherapy of early onset idiopathic chronic pancreatitis: results with long-term follow-up.  Gastrointest Endosc. 2002;  55 488-493
• 24 Jakobs R, Benz C, Leonhardt A. et al . Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients.  Endoscopy. 2002;  34 551-554
• 25 Kozarek R A, Brandabur J J, Ball T J. et al . Clinical outcomes in patients who undergo extracorporeal shock wave lithotripsy for chronic calcific pancreatitis.  Gastrointest Endosc. 2002;  56 496-500
• 26 Farnbacher M J, Schoen C, Rabenstein T. et al . Pancreatic duct stones in chronic pancreatitis: criteria for treatment intensity and success.  Gastrointest Endosc. 2002;  56 501-506
• 27 Karasawa Y, Kawa S, Aoki Y. et al . Extracorporeal shock wave lithotripsy of pancreatic duct stones and patient factors related to stone disintegration.  J Gastroenterol. 2002;  37 369-375
• 28 Rösch T, Daniel S, Scholz M. et al . Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 Patients with long-term follow-up.  Endoscopy. 2002;  34 765-771
• 29 Eickhoff A, Jakobs R, Leonhardt A. et al . Self-expandable metal mesh stents for common bile duct stenosis in chronic pancreatitis: retrospective evaluation of long-term follow-up and clinical outcome of a pilot study.  Z Gastroenterol. 2003;  41 649-654
• 30 Kahl S, Zimmermann S, Glasbrenner B. et al . Treatment of benign biliary strictures in chronic pancreatitis by self-expandable metal stents.  Dig Dis. 2002;  20 199-203
• 31 Telford J J, Farrel J J, Saltzman J R. et al . Pancreatic stent placement for duct disruption.  Gastrointest Endosc. 2002;  56 18-24
• 32 Bradley E L. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992.  Arch Surg. 1993;  128 586-590
• 33 De Palma G D, Galloro G, Puzziello A. et al . Endoscopic drainage of pancreatic pseudocysts: a long-term follow-up study of 49 patients.  Hepatogastroenterology. 2002;  49 1113-1115
• 34 Cortes E S, Maalak A, Le Moine O. et al . Endoscopic cystenterostomy of nonbulging pancreatic fluid collections.  Gastrointest Endosc. 2002;  56 380-386
• 35 Baron T H, Harewood G C, Morgan D E, Yates M R. Outcome differences after endoscopic drainage of pancreatic necrosis, acute pancreatic pseudocysts, and chronic pancreatic pseudocysts.  Gastrointest Endosc. 2002;  56 7-17
• 36 Harewood G C, Wright C A, Baron T H. et al . Impact on patient outcomes of experience in the performance of endoscopic pancreatic fluid collection drainage.  Gastrointest Endosc. 2003;  58 230-235